Calcium channel blockers: an evidence-based review

Area of Science:

• Cardiology
• Pharmacology

Background:

• Calcium channel blockers (CCBs) are frequently prescribed for cardiovascular diseases.
• Their precise therapeutic value and long-term safety profile remain subjects of ongoing debate and research.

Purpose of the Study:

• To evaluate the established clinical trial evidence regarding the efficacy and safety of calcium channel blockers.
• To clarify the appropriate use of CCBs in managing cardiovascular conditions like angina and hypertension.

Main Methods:

• Review of numerous controlled clinical trials with adequate size and duration.
• Analysis of patient populations and specific cardiovascular conditions, including coronary artery disease and heart failure.

Main Results:

• CCB benefits are well-documented for symptomatic control of angina and hypertension.
• Long-term data on hard endpoints like mortality are insufficient, particularly for hypertension.
• Dihydropyridine CCBs show increased risk in coronary disease patients; certain CCBs are detrimental in heart failure with coronary disease.

Conclusions:

• Clinical trial evidence highlights limitations of CCBs, especially concerning long-term outcomes and specific patient groups.
• Practitioners may opt for alternative drug classes with more robustly proven efficacy for hard endpoints.
• Further research is needed to establish the long-term safety of newer CCB formulations.